05:00:07 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



Universal Ibogaine Inc
Symbol IBO
Shares Issued 233,512,849
Close 2024-04-08 C$ 0.02
Market Cap C$ 4,670,257
Recent Sedar Documents

Universal Ibogaine chief clinics officer Rabb departs

2024-04-08 22:20 ET - News Release

Mr. Nick Karos reports

UNIVERSAL IBOGAINE ADVISES OF MANAGEMENT CHANGE

Ian Rabb, chief clinics officer, is no longer with Universal Ibogaine Inc. Mr. Rabb's role with the company's subsidiary, which operates the Kelburn Recovery Centre addiction treatment facility near Winnipeg, Man., will be assumed by Kerri Wilkinson, clinic manager, and Olga Shmelova, Kelburn's clinical director.

Nick Karos, Universal Ibogaine chief executive officer, noted, "The company thanks Mr. Rabb for his past efforts at Kelburn and in advancing the company's ibogaine research mission."

About Universal Ibogaine Inc.

Universal Ibogaine is a life science company, with a mission to transform addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorder and, ultimately, to utilize that treatment protocol globally through planned future licensing agreements.

Universal Ibogaine is concurrently developing a state-of-the-art holistic addiction treatment protocol at its Kelburn Recovery Centre (located near Winnipeg, Man.) that, when paired with the planned ibogaine detox protocol, is intended to revolutionize the way addiction is treated and drastically improve the lives of individuals and families affected by addiction.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.